Ribosomal protein S29 pseudogene 6 (RPS29P6)

RPS29P6 (ribosomal protein S29 pseudogene 6) is a non-coding pseudogene derived from the functional ribosomal protein S29 (RPS29) gene[2][6][9]. Unlike RPS29, which encodes a component of the 40S ribosomal subunit involved in protein synthesis and is associated with diseases such as Diamond–Blackfan anemia[1][3][4][5], RPS29P6 does not produce a functional protein and is not implicated in known biological functions or disease roles. Pseudogenes like RPS29P6 result from duplication or retrotransposition events of functional genes but lack the ability to encode active proteins[2][6][9]. They are not considered therapeutic targets and do not interact with drugs, nor are they used as biomarkers or present safety concerns relevant to pharmacology. Key assessment: - RPS29P6 does not represent a therapeutic target, functional receptor, enzyme, transporter, or protein—it is a processed pseudogene[2][6][9]. - There is no evidence for biological function, disease association, drug interaction, or use as a biomarker. - Given these points, RPS29P6 is not a valid therapeutic or research target, and its listing as a target is incorrect for drug discovery or biomarker studies.

Other names

RPS29_1_32RPS29P6